Leuprolide Acetate; Norethindrone Acetate Patent Expiration
Leuprolide Acetate; Norethindrone Acetate was first introduced by Abbvie Endocrine Inc
Leuprolide Acetate; Norethindrone Acetate Patents
Given below is the list of patents protecting Leuprolide Acetate; Norethindrone Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lupaneta Pack | US6036976 | Sustained release microspheres and preparation thereof |
Dec 13, 2016
(Expired) | Abbvie Endocrine |
Leuprolide Acetate; Norethindrone Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List